Louis Lemberger

4.1k total citations · 1 hit paper
85 papers, 3.2k citations indexed

About

Louis Lemberger is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Louis Lemberger has authored 85 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 28 papers in Cellular and Molecular Neuroscience and 14 papers in Psychiatry and Mental health. Recurrent topics in Louis Lemberger's work include Cannabis and Cannabinoid Research (31 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Neuroscience and Neuropharmacology Research (12 papers). Louis Lemberger is often cited by papers focused on Cannabis and Cannabinoid Research (31 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Neuroscience and Neuropharmacology Research (12 papers). Louis Lemberger collaborates with scholars based in United States, Czechia and Singapore. Louis Lemberger's co-authors include Howard Rowe, Irwin J. Kopin, Julius Axelrod, Richard F. Bergstrom, Ross E. Crabtree, Robert L. Wolen, Nazar Farid, R. F. Bergstrom, Stephen D. Silberstein and Robert Martz and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Louis Lemberger

85 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Marihuana: Studies on the Disposition and Metabolism of Delta-9-Tetrahydrocannabinol in Man

1970 161 citations Louis Lemberger, Julius Axelrod et al. Science profile →

Peers

Countries citing papers authored by Louis Lemberger

Since Specialization

Citations

This map shows the geographic impact of Louis Lemberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Lemberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Lemberger more than expected).

Fields of papers citing papers by Louis Lemberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Lemberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Lemberger. The network helps show where Louis Lemberger may publish in the future.

Co-authorship network of co-authors of Louis Lemberger

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Lemberger. A scholar is included among the top collaborators of Louis Lemberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Lemberger. Louis Lemberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine 1993 ·International Clinical Psychopharmacology ·R. F. Bergstrom, Charles M. Beasley, Nicolas Lévy, Michael Blumenfield, Louis Lemberger	23
2	Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction 1992 ·Clinical Pharmacology & Therapeutics ·Richard F. Bergstrom, (unknown), Louis Lemberger	152
3	Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to man 1988 ·Life Sciences ·(unknown), Howard Rowe, Nagy A. Farid, (unknown), Louis Lemberger	7
4	Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection. 1982 ·Clinical Chemistry ·(unknown), Ronald J. Bopp, (unknown), (unknown), Louis Lemberger	64
5	The pharmacology of ergots: past and present. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Louis Lemberger	5
6	Pharmacologic Effects in Man of a Specific Serotonin-Reuptake Inhibitor 1978 ·Science ·Louis Lemberger, Howard Rowe, (unknown), (unknown), Jong S. Horng, Frank P. Bymaster, David T. Wong	36
7	Cannabis: The Role of Metabolism in the Development of Tolerance 1978 ·Drug Metabolism Reviews ·Louis Lemberger, Alan Rubin	6
8	Effects of lergotrile on schizophrenia & drug induced parkinsonism. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), Marietta H. Klapper, Louis Lemberger	2
9	Subjective Responses and Excretion Patterns of Dextroamphetamine After the Administration of Therapeutic Doses 1977 ·Journal of Forensic Sciences ·(unknown), (unknown), Larry C. Griffis, Robert Martz, Daniel J. Brown, Bruce E. Rodda, Louis Lemberger, R.B. Forney	2
10	The effect of nisoxetine (Lilly compound 94939), a potential antidepressant, on biogenic amine uptake in man. 1976 ·British Journal of Clinical Pharmacology ·Louis Lemberger, (unknown), Howard Rowe, Ruth E. Billings	21
11	The Effect of Lergotrile on Calactorrhea and Gonadotropin Secretion 1975 ·The Journal of Clinical Endocrinology & Metabolism ·Robert E. Cleary, Ross E. Crabtree, Louis Lemberger	12
12	Effects of marihuana combined with secobarbital 1975 ·Clinical Pharmacology & Therapeutics ·William S. Dalton, Robert Martz, Louis Lemberger, Bruce E. Rodda, Robert B. Forney	10
13	Pharmacologic effects and physiologic disposition of delta^6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man 1974 ·Clinical Pharmacology & Therapeutics ·Louis Lemberger, Robert E. McMahon, Robert A. Archer, (unknown), Howard Rowe	15
14	The in vitro and in vivo metabolism of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP). 1973 ·PubMed ·Louis Lemberger, Robert E. McMahon, Robert A. Archer, Ken Matsumoto, Howard Rowe	3
15	THE IN VITRO AND IN VIVO METABOLISM OF Δ6a,10a DIMETHYL HEPTYL TETRAHYDROCANNABINOL (DMHP) 1973 ·Journal of Pharmacology and Experimental Therapeutics ·Louis Lemberger, Robert E. McMahon, Robert A. Archer, Ken Matsumoto, Howard Rowe	1
16	TETRAHYDROCANNABINOL METABOLISM IN MAN 1973 ·Drug Metabolism and Disposition ·Louis Lemberger	21
17	METABOLISM AND DISPOSITION OF Δ9-TETRAHYDROCANNABINOL IN MAN 1971 ·Pharmacological Reviews ·Louis Lemberger, Julius Axelrod, Irwin J. Kopin	10
18	Effect of desmethylimipramine, iprindole and dl-erythro-α-(3,4-dichlorophenyl)-β-(t-butyl amino) propanol HCl on the metabolism of amphetamine 1970 ·Biochemical Pharmacology ·Louis Lemberger, (unknown), (unknown)	33
19	THE METABOLISM OF TYRAMINE IN RABBITS 1966 ·Journal of Pharmacology and Experimental Therapeutics ·Louis Lemberger, A. Klutch, R. Kuntzman	20
20	METABOLISM OF TYRAMINE TO DOPAMINE BY LIVER MICROSOMES 1965 ·Journal of Pharmacology and Experimental Therapeutics ·Louis Lemberger, R. Kuntzman, A. H. Conney, J.J. Burns	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact